Taima TB: 3HP Study
NCT02689089
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
182
Enrollment
OTHER
Sponsor class
Conditions
Tuberculosis
Interventions
DRUG:
3HP
Sponsor
Ottawa Hospital Research Institute
Collaborators
[object Object]
[object Object]